Skip to content

Integrating the Youth Nominated Support Team (YST) With CBT for Black Youth With Acute Suicide Risk: Aim 2b

Integrating the Youth Nominated Support Team (YST) With CBT for Black Youth With Acute Suicide Risk

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07506460
Enrollment
90
Registered
2026-04-01
Start date
2026-03-23
Completion date
2026-08-01
Last updated
2026-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behavior, Behavioral Symptoms, Self-Injurious Behavior, Suicide, Suicide Prevention

Keywords

Black youth, Acute suicide risk, Youth Nominated Support Team, Cognitive Behavioral therapy for Suicide Prevention, Community Mental Health, Suicide prevention, Behavior Therapy, Psychotherapy, Behavioral Disciplines and Activities, Cognitive Behavioral Therapy

Brief summary

This is a second pilot study being completed based on lessons learned from the Aim 2a feasibility pilot study (NCT06941311). Following modifications, the investigators are testing the acceptability, feasibility, and preliminary effectiveness of the combination of two psychosocial interventions, Cognitive Behavioral Therapy for Suicide Prevention (CBT-SP) and the computer-assisted version of the Youth-Nominated Support Team (eYST). In this phase of the study, CBT-SP + eYST will be tested in an open trial (number of youth = 15). Investigators will recruit Black adolescents (ages 12-17) that come to an urban acute care setting for suicidal thoughts and/or self-injurious behaviors to receive the intervention in an outpatient community mental health agency. Participants will receive 12-14 sessions of CBT-SP in addition to YST. Participants will nominate up to 5 caring adults in their lives to serve as support persons. These support persons will attend an education/orientation session to learn more about their role and how to support the youth. Support persons will have weekly contact with the youth and weekly follow up contacts from the youth's clinician/YST intervention specialist. Youth will be assessed at baseline, 6 weeks, and 14 weeks. Parents will be assessed at baseline and 14 weeks. Support persons will be assessed at baseline and 14 weeks. Fidelity assessments will be completed by clinicians after each session, after the YST psycho-ed session, and weekly to document contact with the support team.

Interventions

Clinicians will provide this specialized evidence based mental health care. The study focuses on the acute phase of CBT-SP, which is 12 sessions. CBT-SP's goals are to reduce suicide risk factors, enhance coping, and prevent future suicidal behavior. Identifying the emotional, cognitive, behavioral, or familial processes that precede a suicide crisis is a major focus, which yields an individualized treatment plan. Each session lasts one hour and can be completed either in person or via a secure telehealth platform. Most youths will attend sessions on a weekly basis and therapists will prioritize parent engagement

Youth will nominate up to 5 trusted adults. Following parental approval, Support Persons will attend a psychoeducational orientation session with their assigned intervention specialist (i.e., the youth's clinician), learn about the youth's difficulties, treatment plan, and receive ideas for supporting the youth. Support Persons will be asked to have contact with the youth each week for the 3 months of the study. During these calls, Support Persons have an opportunity to discuss any questions or concerns they may have about the youth and how best to support them.

Sponsors

University of Michigan
Lead SponsorOTHER
National Institute of Mental Health (NIMH)
CollaboratorNIH
MiSide
CollaboratorUNKNOWN
Children's Hospital of Michigan
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

This study will recruit 15 youth and 15 parents/guardians, as well as up to 60 support individuals.

Eligibility

Sex/Gender
ALL
Age
12 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Youth Inclusion Criteria: * Patients that are able to provide at least one verifiable contact for emergency or tracking purposes * Willing to receive care at MiSide * Present to an acute emergency care setting with suicide risk (per protocol) * Self-identify as Black * Willing and able to complete enrollment procedures * Willing and able to provide signed and dated informed assent Youth

Exclusion criteria

* Unable to be consented in English * Do not have a parent/legal guardian available to provide consent * Are not able to provide informed assent or to participate in the assessment due to significant agitation, psychosis, cognitive impairment, learning disability, or medical trauma * Actively engaged in specialty mental health treatment * Participated in the Aim 2a open trial Parent/Guardian Inclusion Criteria: * Adults 18 years and older * The parent or legal guardian of a youth participating in this Aim * Understand written and spoken English * Willing and able to complete enrollment procedures * Willing and able to provide signed and dated informed consent * Need to have access to technology, either cell or an email address Parent/Guardian

Design outcomes

Primary

MeasureTime frameDescription
Acceptability - percent of eligible youth consentedBaselineThe intervention will be considered acceptable if at least 50% of eligible youth approached for participation choose to enroll in the study.
Feasibility - Mean number of support people6 weeksThe intervention will be considered feasible if the mean number of support people per youth is at least 3.
Acceptability - Mean number of support person contacts14 weeksThe intervention will be considered acceptable if the mean number of support person contacts with youth is at least 7.
Feasibility - Number of CBT-SP sessions attended14 weeksNumber of CBT-SP sessions attended by youth

Countries

United States

Contacts

CONTACTChristina Magness, LMSW
cmagness@med.umich.edu734-252-6315
PRINCIPAL_INVESTIGATORCynthia Ewell Foster, PhD

University of Michigan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 2, 2026